Breaking language barriers in childhood cancer care
NCT ID NCT05425992
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study interviews Spanish-speaking families of children with leukemia or lymphoma to learn about their experiences and challenges. Researchers want to understand what works well and what barriers exist in communication and access to care. The goal is to use these insights to build a stronger, more supportive medical home for these families.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could identify ways to make cancer care more accessible and supportive for Spanish-speaking families.
- What could go wrong
- This is a small, early-stage interview study with only 20 participants, so findings may not apply to all families. It aims to gather insights, not test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 20 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2022
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients eligible for enrollment are identified from EPIC electronic medical record with notification for newly diagnosed families of Spanish language preference.
- Ages
-
Up to 22 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 0 to 22 years of age * Diagnosis of leukemia or non-Hodgkin lymphoma * Spanish as preferred language for patient, parent or guardian * Received or receiving care at the Center for Cancer and Blood Disorders (CCBD) Exclusion Criteria: * Patients without oncologic diagnosis * Patients with parents whose language preference is English * Patients who received care solely outside of the CCBD
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Leukemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Children's Hospital Colorado
RECRUITINGAurora, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Double-Drug attack on Hard-to-Treat lymphomas
- Patient's own t cells engineered to hunt lymphoma in early trial
- Immunotherapy injection tested against Hard-to-Treat childhood lymphoma
- Can a Nine-Week group program help blood cancer patients grow through trauma?
- Two-Drug combo aims to push CLL into deep remission
- Vaccine aims to train immune system against blood cancers